Physician profile
Seth Winslow
NPI 1568734135
$536.63
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $54.94 · 2020: $33.94 · 2021: $148 · 2022: $70.21 · 2023: $154 · 2024: $76.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $177.29 | 2021-2023 | Ubrelvy, Qulipta, Vraylar |
| Takeda Pharmaceuticals U.S.A., INC. | $134.31 | 2022-2024 | Vpriv |
| Phadia US INC. | $54.08 | 2019-2023 | Immunocap |
| Phathom Pharmaceuticals, INC. | $38.14 | 2024 | Voquezna |
| Redhill Biopharma INC. | $23.86 | 2021 | |
| Merck Sharp & Dohme LLC | $21.00 | 2024 | Verquvo |
| Smith+Nephew, INC. | $20.79 | 2023 | Collagenase Santyl |
| Genentech USA, INC. | $19.07 | 2020 | |
| Shire North American Group INC | $18.63 | 2019 | |
| Sunovion Pharmaceuticals INC. | $14.87 | 2020 | |
| Ironwood Pharmaceuticals, INC | $14.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Winslow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.